Thank you for Subscribing to Life Science Review Weekly Brief
COVID-19 At-Home Test — the first at-home COVID-19 test COVID-19 rapid antigen test will utilize computer vision technology in a smartphone to interpret and display testing results digitally. There is no need for a prescription, a laboratory, or a lengthy wait for results.
Fremont, CA: BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology leader, has declared that the US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the BD Veritor. COVID-19 At-Home Test — the first at-home COVID-19 test COVID-19 rapid antigen test will utilize computer vision technology in a smartphone to interpret and display testing results digitally. There is no need for a prescription, a laboratory, or a lengthy wait for results.
This new rapid, digitally read lateral flow antigen self-test was developed by BD to make COVID-19 testing quicker for people to complete in the privacy and safety of their own homes. The test will first be made available to businesses, schools, and governments that want to provide a self-testing option for their employees or students.
The BD Veritor At-Home COVID-19 Test will use a simple, painless nasal swab and an easy-to-use Scanwell Health mobile app to provide reliable test results in 15 minutes. The app, which is available for iOS and Android, walks you through the process of collecting and transferring the nasal swab sample to the test stick. The camera on the mobile device is then used to capture, analyze, and interpret the results, removing the human subjectivity of a visually read test.
"The rise in COVID-19 cases from the Delta variant has increased the demand for at-home testing, and the BD Veritor At-Home COVID-19 Test is an easy-to-use test with definitive digital results that is ideal for use in the home," stated Dave Hickey, president of Life Sciences for BD. "New mandates from governments and businesses are specifying the need for periodic testing for those who cannot or chose not to be vaccinated, and this new test may help businesses, governments or schools fulfill those requirements."